Journal of Neurology

, Volume 254, Issue 2, pp 228–235

A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy



There is insufficient evidence to support the use of exercise in the management of chronic disablement in people with inflammatory peripheral neuropathy. Therefore, our study aimed to determine the feasibility and effectiveness of a physiotherapist prescribed community based exercise programme for reducing chronic disablement in patients with stable motor neuropathy.

We assessed the effects of a 12  week unsupervised, community based strengthening, aerobic and functional exercise programme on activity limitation and other measures of functioning in 16 people with stable motor neuropathy and 10 healthy control subjects.

Fourteen of 16 patients and 8 out of 10 healthy control subjects completed the study and exercised safely in the community with no adverse events. Significant improvements were seen in all measures of activity limitation and in wider measures of health including anxiety, depression and fatigue in the patient group. Improvements were sustained at six months after completion of the exercise programme, except for depression. Ten patients continued to exercise regularly at six months.

These findings demonstrate that individually prescribed community based exercise is feasible and acceptable for people with stable motor neuropathy and participation in exercise may be successful in reducing chronic disablement. Future randomised controlled trials are needed to examine the efficacy of this complex community based intervention.


exercise peripheral neuropathy Guillain-Barré syndrome physical therapy disability 


  1. 1.
    Agre JC, Rodriquez A, Franke T (1997) Strength, Endurance and work capacity after muscle strengthening exercise in post polio subjects. Arch Phys Med Rehab 78:681–686CrossRefGoogle Scholar
  2. 2.
    American College of Sports Medicine (1995) ACSM’s guidelines for exercise testing and prescription. Williams & Wilkins, PhiladelphiaGoogle Scholar
  3. 3.
    Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27:S21–S24PubMedCrossRefGoogle Scholar
  4. 4.
    Ashworth N, Chad K, Harrison E, Reeder B, Marshall S (2005) Home versus center based physical activity programs in older adults. Cochrane Database Syst RevCD004017Google Scholar
  5. 5.
    Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32PubMedCrossRefGoogle Scholar
  6. 6.
    Bouchard C, Lacroix C, Plante V, Adams D, Chedru F, Guglielmi JM, Said G (1999) Clinicapathological findings and prognosis of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Neurology 52:498–503PubMedGoogle Scholar
  7. 7.
    de Jager AEJ, Minderhoud JM (1991) Residual signs in Guillain-Barré syndrome: analysis of 57 patients. J Neurol Sci 104:151–156PubMedCrossRefGoogle Scholar
  8. 8.
    Dishman RK (1990) Determinants of participation in physical activity. In: Bouchard C (ed) Exercise, Fitness and Health. Human Kinetics, Champaign, llinois, pp. 75–100Google Scholar
  9. 9.
    Dornonville de la CC, Jakobsen J (2005) Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome. Neurology 64:246–253Google Scholar
  10. 10.
    Duncan P, Richards L, Wallace D, Stoker-Yates J, Luchies P, Ogle A, Studenski S (1998) A randomized controlled pilot study of a home based exercise program for individuals with mild and moderate stroke. Stroke 29:2055–2060PubMedGoogle Scholar
  11. 11.
    Fox K (1999) The influence of physical activity on mental well-being. Public Health Nutr 2:411–418PubMedGoogle Scholar
  12. 12.
    Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA (2004) Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP. Neurology 63:2393–2395PubMedGoogle Scholar
  13. 13.
    Hawe P, Shiell A, Riley T (2004) Complex interventions: how “out of control” can a randomised controlled trial be? BMJ 328:1561–1563PubMedCrossRefGoogle Scholar
  14. 14.
    Hughes RA, Bensa S, Willison HJ, Van der Bergh P, Comi G, Illa I, Nobile-Orazio E, Van Doorn P, Dalakas M, Bojar M, Swan A (2001) Randomized Controlled Trial of Intravenous Immunoglobulin Versus Oral Prednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Ann Neurol 50:195–201PubMedCrossRefGoogle Scholar
  15. 15.
    Hughes RA, Rees JH (1997) Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 176:S92–S98PubMedGoogle Scholar
  16. 16.
    Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM (1994) The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 75:560–563PubMedGoogle Scholar
  17. 17.
    King AC, Haskell WL, Taylor CB, Kraemer HC, DeBusk RF (1991) Group- vs home-based exercise training in healthy older men and women. A community-based clinical trial. JAMA 266:1535–1542PubMedCrossRefGoogle Scholar
  18. 18.
    Krupp LB, Coyle PK, Doscher NP, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R (1995) Fatigue therapy in multiple sclerosis: results of a double blind, randomized, parallel trial of amantadine, pemoline and placebo. Neurology 45:1956–1961PubMedGoogle Scholar
  19. 19.
    Lennon SM, Koblar S, Hughes RA, Goeller J, Riser AC (1993) Reasons for persistent disability in Guillain Barré Syndrome. Clin Rehabil 7:1–8CrossRefGoogle Scholar
  20. 20.
    Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK (1999) Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66:677–680PubMedGoogle Scholar
  21. 21.
    McDonald CM (2002) Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 81:S108–S120PubMedCrossRefGoogle Scholar
  22. 22.
    Merkies IS, Schmitz PI, Samijn JP, van der Meché FG, van Doorn PA (1999) Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 53:1648–1654PubMedGoogle Scholar
  23. 23.
    Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA, Inflammatory Neuropathy Cause, Treatment (INCAT) group (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72:596–601PubMedCrossRefGoogle Scholar
  24. 24.
    Merkies IS, Schmitz PI, van der Meché FG, Samijn JP, van Doorn PA, Inflammatory Neuropathy Cause, Treatment (INCAT) group (2002) Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 59:84–91PubMedGoogle Scholar
  25. 25.
    Merkies ISJ, Schmitz PIM, van der Meché FGA, Samijn JPA, van Doorn PA (2003) Connecting impairment, disability, and handicap in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 74:99–104PubMedCrossRefGoogle Scholar
  26. 26.
    Mullis R, Campbell IT, Wearden AJ, Morriss RK, Pearson DJ (1999) Prediction of peak oxygen uptake in chronic fatigue syndrome. Br J Sports Med 33:352–356PubMedGoogle Scholar
  27. 27.
    Nicolas G, Maisonobe T, Le Forestier N, Leger J, Bouche P (2002) Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 25:26–30PubMedCrossRefGoogle Scholar
  28. 28.
    Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, Hugos C, Kraemer DF, Lawrence J, Mass M (2004) Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62:2058–2064PubMedGoogle Scholar
  29. 29.
    Perenger TV (1998) What’s wrong with Bonferroni Adjustments? BMJ 316:1236–1238Google Scholar
  30. 30.
    Rothwell PM, McDowell Z, Wong CK, Dorman PJ (1997) Doctors and patients don’t agree: Cross sectional study of patient’s and doctors’ perceptions and assessments of disability in multiple sclerosis. BMJ 314:1580–1583PubMedGoogle Scholar
  31. 31.
    Ruhland JLS (1997) The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 77:1026–1039PubMedGoogle Scholar
  32. 32.
    Santiago M, Coyle C (2004) Leisure-time physical activity and secondary conditions in women with physical disabilities. Disabil Rehabil 26:485–494PubMedCrossRefGoogle Scholar
  33. 33.
    Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D (2000) Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci 21:31–37PubMedCrossRefGoogle Scholar
  34. 34.
    Villeneuve PJ, Morrison HI, Craig CL, Schaubel DE (1998) Physical activity, physical fitness, and risk of dying. Epidemiology 9:626–631PubMedCrossRefGoogle Scholar
  35. 35.
    Ware JE, Kosinski M (2003) SF-36 Physical and mental health summary scales: A manual for users of version 1. QualityMetric Incorporated, LincolnGoogle Scholar
  36. 36.
    Ware JE, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). Med Care 30:473–483PubMedCrossRefGoogle Scholar
  37. 37.
    Weyerer S, Kupfer B (1994) Physical exercise and psychological health. Sports Med 17:108–116PubMedCrossRefGoogle Scholar
  38. 38.
    White CM, Pritchard J, Turner-Stokes L (2004) Exercise for people with peripheral neuropathy. Cochrane Database Syst RevGoogle Scholar
  39. 39.
    White LJ, McCoy SC, Castellano V, Gutierrez G, Stevens JE, Walter GA, Vandenborne K (2004) Resistance training improves strength and functional capacity in persons with multiple sclerosis. Mult Scler 10:668–674PubMedCrossRefGoogle Scholar
  40. 40.
    Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM (1996) Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehab 77:64–69CrossRefGoogle Scholar
  41. 41.
    Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 87:361–370Google Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2007

Authors and Affiliations

  1. 1.Applied Biomedical Research DivisionShepherd’s House, Guy’s Campus, King’s College LondonLondonUK
  2. 2.Dept. of Clinical Neuroscience, School of MedicineKing’s College LondonLondonUK

Personalised recommendations